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To identify neurotoxic factors in meningitis, a neuronal cell line (HN33.1) was exposed to
cerebrospinal fluid (CSF) obtained from rabbits with pneumococcal meningitis or Escherichia
coli meningitis or 2 hand 6 h after meningitis was induced by proinflammatory bacterial prod-
ucts (pneumococcal cell walls, endotoxin). CSF from all types of meningitis induced similar
degrees of cytotoxicity. When a soluble tumor necrosis factor (TNF) receptor that completely
blocked TNF-mediated toxicity at 10- 7 M was used, all toxicity in meningitis caused by E. coli,
endotoxin, or pneumococcal cell wall administration (2 h afterwards) was mediated by TNF. In
contrast, CSF from animals with meningitis caused by live pneumococci or pneumococcal cell
wall injection (6 h afterwards) retained cytotoxicity in the presence of the TNF receptor. Thus, in
established pneumococcal meningitis, but not in the other forms of meningitis, TNF is not the
only component toxic in this neuronal cell line.
Brain damage is the most important complication in survi-
vors of bacterial meningitis. The spectrum of sequelae in-
cludes mental retardation, learning disabilities, and focal
neurologic deficits, indicating that meningitis causes injury
to neurons [I, 2]. Little is known about the processes leading
to neuronal injury. Both ischemia and toxic effects of factors
generated by the inflammation in the subarachnoid space
have been implicated in contributing to neuronal dysfunc-
tion and injury [3-5]. However, it is difficult to identify the
role of potential neurotoxic factors in vivo in a disease that
results in highly complex pathophysiologic changes.
To study neuronal injury during meningitis, we developed
a new approach that combines in vitro and ex vivo elements.
The studies were designed to test the hypothesis that soluble
factors generated by the infection and inflammation during
meningitis contribute to neuronal injury. We assumed that
such neurotoxic factors, in addition to acting directly on neu-
rons, are released into the cerebrospinal fluid (CSF), thus
allowing us to use CSF from animals with meningitis as the
source. We used a murine neuronal cell line (HN33.1) [6],
which shows important neuron-specific characteristics, and a
soluble TNF receptor [7] to examine whether .infected CSF
contains cytotoxic factors. CSF from animals with meningitis
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induced by both gram-positive and gram-negative live organ-
isms and by proinflammatory bacterial components was ex-
amined in the cell culture system.
Material and Methods
Experimental meningitis. Meningitis was induced in New
Zealand White rabbits, 2-3 kg, by various stimuli as described
below. Animals were anesthetized with an intramuscularly ad-
ministered mixture of acepromazine, 0.5-1.0 mg/kg (Promace;
Aveco, Fort Dodge, IA), ketamine, 35-50 mg/kg (Ketaset; Bris-
tol Laboratories, Syracuse, NY), and xylazine, 2-5 mg/kg (Gem-
ini; Rugby Laboratories, Rockville, NY). The cisterna magna
was directly punctured by a 25-gauge butterfly needle, and 0.3
mL of the inoculum was injected into the CSF. After the time
intervals indicated below, animals were anesthetized again, and
inflamed CSF was collected by a second puncture of the cisterna
magna (0.5-1.0 mL ofCSF/animal). CSF was immediately cen-
trifuged at 8000 g for 5 min, pooled for groups of 5-8 animals,
and stored at -70°C. The severity of meningitis was quantitated
in pooled CSF by determining CSF lactate and glucose concen-
trations [8] with an automatic lactate/glucose analyzer (2300
STAT; Yellow Springs Instruments, Yellow Springs, OH). Steril-
ity of the samples before use in the cell culture system was con-
firmed by culturing 0.1 mL on blood agar plates.
Live pneumococcal meningitis. Streptococcus pneumoniae
type 3 was used to produce meningitis [8]. The organism was
grown on blood agar plates, harvested in saline, and stored at
-70°C. To induce meningitis, the inoculum was thawed and
diluted to 106 cfu/ml. in normal saline. Eighteen hours after
intracisternal injection of the inoculum, when animals showed
signs of disease (fever, lethargy), a single dose of ceftriaxone
(150 mg/kg) was administered through an ear vein to treat men-
ingitis. Three hours later, CSF was collected and processed as
described above. In control experiments designed to examine
whether in vitro growth ofpneumococci in CSF produced prod-
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ucts that were toxic to HN33.1 cells, S. pneumoniae was grown
for 6 h in vitro in normal rabbit CSF. Subsequently, the culture
was sterilized by adding 10 J,tg/mLceftriaxone for 4 h, followed
by centrifugation (8000 g for 10 min) to remove residual bacte-
ria. In a second preparation, cultures were centrifuged (8000 g
for 10 min) and pneumococci were then disrupted by vigorous
sonication. In both cases, sterility of the preparation was con-
firmed before the experiments in the cell culture system. In ad-
dition, control experiments using filter sterilization ofCSF with
0.2-J,tm filters (Sterile Acrodisc; Gelman Sciences, Ann Arbor,
MI) showed no effect of the filtration step on the cytotoxicity
induced by CSF from animals with pneumococcal meningitis.
Meningitis induced by pneumococcal cell wall. Pneumococ-
cal cell walls were prepared as described by Tuomanen et al. [9].
Briefly, a rough strain of S. pneumoniae (R6) was grown in
Todd-Hewitt medium to stationary phase, harvested in saline,
and boiled for 15 min to inactivate autolytic enzymes. Bacterial
cells were then disrupted using glass beads. The resulting crude
cell wall preparation was washed twice in boiling 2%SDS, incu-
bated with DNase, RNase, and trypsin, extensively washed in
distilled water, suspended in saline, and stored at -70°C. Cell
wall preparation (10-30 J,tg, equivalent to --108 cfu) was in-
jected intracisternally in 0.3 mL; 2 and 6 h later, CSF was col-
lected and processed as described above. In control experi-
ments, the same cell wall preparation was added to the cell
culture medium.
Live Escherichia coli meningitis. A Kl-positive strain of E.
coli was used for these experiments. The organism was grown in
trypticase soy broth to logarithmic phase, washed, and resus-
pended in saline, and rabbits were injected intracisternally with
2 X 106 cfu; 14 h later, when animals were clinically ill, antibi-
otic treatment was initiated with one intravenous dose of cef-
triaxone or cefotaxime (150 rug/kg). Three hours later, CSF was
collected and processed as described above. In control experi-
ments, supernatants from E. coli cultures grown in vitro in CSF
were used after sterilization of the culture with 10 J,tg/mL cef-
triaxone and centrifugation (8000 g for 5 min).
Meningitis induced by endotoxin. Endotoxin from rough Sal-
monella minnesota Re 595 was purchased from Sigma (St.
Louis). Stock solutions were prepared by suspending 10 mg of
endotoxin in 2 mL of 20 mM EDTA, followed by sonification.
Aliquots were kept at -70°C. To induce meningitis, stock solu-
tion was diluted 1:100 in saline and filter sterilized (0.2-J,tm
filters), and 10 J,tg of endotoxin was injected intracisternally; 2
and 6 h later CSF pools were generated. The identical endotoxin
preparation was also used directly in the cell culture system at a
concentration of 30% (vol/vol).
Other reagents. Recombinant human (rh) TNFa was a gift
from Genentech (South San Francisco). Stock solutions were
made in saline containing 0.2% bovine serum albumin and kept
at 4°C. Appropriate final concentrations were prepared in cul-
ture medium. Recombinant human soluble TNF receptor con-
sisted of the extracellular portion of the 55-kDa human TNF
receptor, as previously described [7, 10]. Recombinant human
interleukin-la (rhIL-la) was a gift from Hoffmann-La Roche
(Nutley, NJ). Stock solutions in distilled water were kept at 4°C,
and final concentrations were prepared in culture medium. Glu-
tamate was purchased from Sigma, and solutions were prepared
freshly for each experiment in culture medium. Arachidonic
acid was purchased from Sigma and was dissolved in Krebs-
Ringer buffer to yield a 1 mM concentration.
Neuronal cell line HN33.1. This cell line was generated by
the fusion of hippocampal neurons from young adult mice with
a neuroblastoma cell line (gift ofB. Wainer, University of Chi-
cago) [6]. HN33.1 cells show important features characteristic
ofneurons, such as the presence ofneuritic processes, neurofila-
ment protein, and membrane excitability typical for hippocam-
pal neurons. In these regards the cell line is distinct from the
neuroblastoma parent cell line [6]. HN33.1 cells were grown in
Dulbecco's modified Eagle medium (DMEM) supplemented
with 10% fetal calf serum and 100 units/nil, penicillin G and
100 J,tg/mL streptomycin in tissue culture 96-well microtiter
plates (Falcon Primaria; Becton Dickinson, Lincoln Park, NJ) at
37°C in room air containing 5% CO2 , When the cells reached
75%-90% confluence, the culture medium was changed to fresh
medium and the cells were exposed to the various stimuli for 48
h. The highest concentration ofCSF and bacterial supernatants
examined in these experiments was 30% (vol/vol). All experi-
ments were done in triplicate wells, and culture medium alone
and native CSF were included as controls.
Cytotoxicity assay. Cytotoxicity was assessed by measuring
leakage of lactate dehydrogenase (LDH) into the culture super-
natant by a commercial assay (Sigma). Centrifuged medium
( 100 J,tL) from each cell culture well was added to 1 mL of
reagent solution according to the manufacturer's instructions,
and the reduction ofNAD resulting from oxidation oflactate to
pyruvate was measured at 340 nm on a spectrophotometer (DU-
70; Beckmann, Duarte, CA). LDH contained in the culture me-
dium (mean, 59 units/rnl.) and in CSF-containing medium
(mean, 115 units/ml, for live pneumococcal meningitis, the
pool with the highest LDH content) was subtracted and the net
LDH release was then expressed as percentage of control wells
(LDH releases in control wells = 100%). Cytotoxicity was rou-
tinely confirmed in all experiments by simultaneous micro-
scopic quantitation of dead cells stained with 0.4% trypan blue
for 5 min.
Statistics. Results of an individual experiment were calcu-
lated as mean ± SD for triplicate wells. Results presented here
are mean ± SD of four to eight independent experiments. Com-
parison between groups was done by Student's t test, adjusted
for multiple comparisons by the Bonferroni correction. Data
that did not show a normal distribution were analyzed by the
Mann-Whitney rank sum test.
Results
Characteristics of CSF pools. Infection with either S.
pneumoniae or E. coli produced profound inflammatory
changes in the CSF, with polymorphonuclear pleocytosis
and markedly increased lactate concentrations and reduced
glucose concentrations (table I). Lactate concentrations
were higher in animals infected with E. coli than in animals
infected with S. pneumoniae (P < .01), while glucose con-
centrations were similar. Lactate and glucose concentrations
in CSF 2 h after intracisternal injection ofpneumococcal cell
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Table 1. Lactate and glucose concentrations in CSF pools from
rabbits with different forms of bacterial meningitis.
Lactate Glucose
Pool (n) (mmol/L) (mg/IOO mL)
Normal controls (6) 1.7 ± 0.2* 116 ± 4
Pneumococcal meningitis
Live Streptococcus pneumoniae (5) 11.2 ± 1.9t 71 ± 36t
Cell wall 2 h (4) 2,9 ± 0.8 146 ± 15t
Cell wall 6 h (4) 8.3 ± 1.5 114 ± 24
Gram-negative meningitis
Live Escherichia coli (3) 14.5 ± 1.6t 70 ± 24t
LPS 2 h (4) 3.2 ± 0.4 105 ± 20
LPS 6 h (4) 9.7± 1.5 80 ± 45 t
NOTE. LPS = lipopolysaccharide. n = no. of CSF pools used.
* p < .0 I vs. all meningitic CSF.
t P< .01.
t P < .0 I vs. controls.
wall or endotoxin showed only mild abnormalities compared
with normal control levels (table I). These CSF pools, how-
ever, contain high concentrations of various cytokines, in-
cluding TNF at '"2 X 10-9 M concentration, IL-l, and IL-6
[11-13]. Four hours later, both bacterial stimuli had induced
a typical inflammatory response, with CSF pleocytosis and
markedly increased lactate concentrations that were similar
to those found in animals infected with live organisms (table
I). Pneumococcal cell wall did not cause a reduction in CSF
glucose concentrations, while endotoxin did (table I).
Cytotoxicity induced by pools of infected CSF. CSF from
all six types of meningitis produced substantial cytotoxicity
in HN33.1 cells when the cells were exposed to culture me-
dium containing 30% CSF (vol/vol) for 48 h. Net LDH re-
lease averaged 40.5 units/mi. ofsupernatant in control wells
and increased to 311.3 units/rnl, in wells exposed to CSF
from animals with live pneumococcal meningitis. Values for
other CSF pools were similar, and LDH release, when nor-
malized for controls, increased by --600%-900% (table 2).
There was no significant difference in the degree ofcytotoxic-
ity between the six CSF preparations examined (table 2).
Results of LDH measurements were confirmed by examina-
tion of the cultures after trypan blue staining; with at least
30%-50% of the exposed cell showing evidence of injury,
while < I%ofcontrol cells were trypan blue-positive. Native
CSF at 30%(vol/vol) and CSF from infected animals at con-
centrations of <10% (vol/vol) did not lead to increased LDH
release or evidence of injury by trypan blue staining, while
there was increasing toxicity at concentrations of 15%-30%
(vol/vol) of infected CSF. Filter sterilization of the CSF
pools did not affect the degree of cytotoxicity.
Effect ofsoluble TNF receptor on cytotoxicity ofmeningitic
CSF. We found that rhTNFa at concentrations as low as 5
X 10-11 Minduced significant release ofLDH from HN33.1
cells, while maximal LDH release was induced by 5 X 10-8
M. Since CSF from animals with experimental meningitis
due to various bacterial stimuli has been shown to contain
'" 10- 9 M TNFa [11-13], we used a soluble TNF receptor to
determine to what extent the cytotoxicity of CSF could be
accounted for by the presence ofTNF [7]. Experiments with
rhTNF showed that between 10- and 100-fold molar excess
of the receptor completely blocked the cytotoxicity of
rhTNFa (table 2). We therefore used the receptor at 10- 8
and 10-7 M concentrations in the experiments with CSF
from rabbits with meningitis. The receptor alone was not
toxic when added to the culture. At the higher concentration
examined, the receptor completely blocked the cytotoxicity
ofCSF from animals with meningitis caused by E. coli, endo-
toxin, or injection of pneumococcal cell wall (after 2 h) (ta-
ble 2). In contrast, cytotoxicity ofCSF from animals with S.
pneumoniae meningitis was only partially blocked by the re-
ceptor (P < .00 I compared with rhTNF) (table 2). Cytotoxic-
ity from CSF obtained 6 h after injection of pneumococcal
cell wall was also not completely blocked by the TNF recep-
tor (P = .0 I vs. rhTNF) (table 2).
Cytotoxicity of bacterial products. Since CSF from ani-
mals with pneumococcal but not gram-negative meningitis
seemed to contain a factor other than TNF that is cytotoxic
for HN33.1 cells, we examined whether various sterile prepa-
rations obtained from pneumococcal cultures were toxic to
the cell line in vitro. Adding the cell wall preparation used to
produce meningitis at 30%(vel/vel) to the cell culture led to
an increased release of LDH to 250.1 %± 26.8% of controls
(P < .0 I), while concentrations of ~20% were not toxic. In
contrast, CSF in which pneumococci had been grown in vi-
tro and then killed by antibiotics, pneumococci disrupted by
sonication, or rough, heat-killed pneumococci (strain R6)
Table 2. Lactate dehydrogenase (LDH) release from HN33.1
cells after exposure to recombinant human tumor necrosis factor
(rhTNFa) or CSF from various forms of meningitis in the absence
or presence of soluble TNF receptor.
Receptor concentration
Stimulus None (n) 10-8 M (n) 10-7 M (n)
rhTNFa ( I0- 9 M) 534 ± 237 (8) 136 ± 71 (8) 74 ± 20 (4)*
Meningitic CSF (30%)
Live Streptococcus
pneumoniae 750 ± 378 (9) 334 ± 152 (9)t 323 ± 122 (6)t
Cell wall 2 h 995 ± 257 (6) 113 ± 38 (6) 80±43(3)
Cell wall 6 h 779 ± 307 (9) 279 ± 205 (9)* 248 ± 205 (6)*
Live Escherichia
coli 713±271(7) 113 ± 41 (7) 108 ± 9 (4)
LPS 2 h 705 ± 445 (4) 57±43(4) ND
LPS 6 h 896 ± 396 (7) 106 ± 62 (7) 90±43(4)
NOTE. Data are % of control. LPS = lipopolysaccharide: n = no. of
independent experiments. ND = not done.
t P < .009 vs. other groups except cell wall 6 h.
* P = .0 I (by Mann-Whitney rank sum).
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were not toxic at the highest concentrations examined
( -- 107 cfu/rnl., corresponding to the CSF titers in vivo). En-
dotoxin at 10 JLg/mL and CSF in which E. coli had been
grown in vitro at 30% (vol/vol) concentrations also were not
toxic.
Cytotoxicity ofother components ofinfected CSF. Compo-
nents of infected CSF that can potentially be cytotoxic in-
clude cytokines other than TNF (e.g., interleukins), excit-
atory amino acids (glutamate and aspartate), and
arachidonic acid released from neutrophil cell membranes.
IL-l a at concentrations up to 10- 8 M and the excitatory
amino acid glutamate at concentrations up to I mM were not
toxic to HN33.1 cells. Arachidonic acid at 1 X 10-3 M and 5
X 10-4 M led to significant increases in LHD (359.3% ±
11.9% and 230.1 % ± 35.3% of controls, respectively; P <
.01), while lower concentrations were not toxic.
Discussion
The spectrum of neurologic sequelae caused by bacterial
meningitis provides good evidence for the occurrence ofneu-
ronal injury during meningitis. Work in animal models has
provided insights into the molecular mechanisms of inflam-
mation and into the pathophysiology of the disease [4, 5],
but in general animal models have not conclusively demon-
strated a causal relationship between these changes and neu-
ronal injury. The main purpose of the present studies was
therefore to develop an in vitro approach to examine the
process of neuronal injury during bacterial meningitis.
Clinical studies showing a beneficial effect of dexametha-
sone in children with bacterial meningitis [14, 15] and ani-
mal studies indicate that components of the inflammation
generated during meningitis contribute to brain injury [16-
18]. These observations prompted us to explore in vitro the
presence of cytotoxic factors generated during meningitis.
Since the primary site ofinfection and inflammation in men-
ingitis is the subarachnoid space, we examined CSF from
animals with meningitis. Ultimately, it will be necessary to
show in vivo that cytotoxic factors identified in the CSF dur-
ing meningitis produce their toxic effects on neurons within
brain tissue. However, there are clearly similarities between
the disease process in the subarachnoid space and events in
the brain. In both animal models and humans with meningi-
tis the inflammatory process is not confined to the subarach-
noid space but involves focal areas of the brain, thereby gen-
erating inflammatory products directly within brain tissue
[19-21]. Furthermore, proteins can diffuse from the CSF
into the brain [22]. This diffusion likely explains why the
injection of cytokines into the CSF of experimental animals
has profound effects on the brain and induces diffuse brain
edema [17].
We induced meningitis with both live organisms and prod-
ucts of these meningeal pathogens that are responsible for
initiating the inflammatory response during meningitis [9,
23] to examine whether our system detected biologic differ-
ences between, for example, pneumococcal and E. coli men-
ingitis or between meningitis induced by live organisms and
by sterile bacterial products. We were initially surprised that
CSF from animals with all forms of meningitis was neuro-
toxic in vitro to very similar degrees, despite the fact that
changes in the CSF formula were much less pronounced 2 h
after intracisternal injection of a sterile bacterial stimulus
than they were 20 h after induction of meningitis by live
organisms. However, the results can be explained by the im-
portance ofTNF in this system that used a TNF-sensitive cell
line. Cytokines in the CSF peak --2 h after intracisternal
injection of proinflammatory bacterial products, and after 6
h the concentrations are still in a range cytotoxic for HN33.1
cells [11, 12]. In animals with meningitis induced by live
organisms, TNF concentrations are especially high shortly
after beginning antibiotic therapy, which leads to increased
release of TNF through the liberation of bacterial products
[11, 24, 25]. Thus, all CSF samples tested in our study con-
tained high TNF concentrations sufficient to induce close to
maximal cytotoxicity in the HN33.1 cells.
The use ofa soluble 55-kDa TNF receptor proved to be a
valuable tool to further examine the cytotoxicity of infected
CSF in our in vitro model [7, 10]. The complete blockage of
the cytotoxicity of rabbit TNF in inflamed CSF by the hu-
man receptor molecule documented that the neutralizing ca-
pacity of the receptor was less susceptible to species varia-
tions of the TNF molecule than was a mouse monoclonal
antibody (provided by Cutter Laboratories, Berkeley, CA),
which effectively neutralized rhTNFa in our system but was
ineffective in blocking the cytotoxicity of CSF from rabbits
with meningitis (data not shown). The results obtained with
the receptor indicate that TNF was the only component
toxic to the HN33.1 cells in the CSF from animals with men-
ingitis caused by gram-negative stimuli (live bacteria and en-
dotoxin) and early after the induction ofmeningitis by pneu-
mococcal cell wall. In contrast, significant cytotoxicity
remained despite high doses of TNF receptor in CSF from
animals with established pneumococcal meningitis. This
suggests a fundamentally different neurotoxic potential in
pneumococcal than in gram-negative meningitis. It remains
to be determined whether this non-TNF-mediated cytotoxic-
ity of pneumococcal meningitis contributes to the high rate
of central nervous system injury and mortality observed in
pneumococcal meningitis [26-28].
The reasons for the different cytotoxic profiles ofpneumo-
coccal and E. coli meningitis are unclear. CSF inflammation
was not more pronounced in pneumococcal meningitis, and
TNF concentrations in CSF during pneumococcal meningi-
tis are not higher than in E. coli meningitis (Tureen JH, Lau
A, personal communication). Also, the difference appar-
ently is not explained by direct toxicity of components de-
rived from pneumococci. The fact that non-TNF-mediated
toxicity could be induced by the cell wall preparation indi-
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cates that bacterial products such as pneumolysin or lipo-
teichoic acid were not responsible for this cytotoxicity, since
they are inactivated during preparation ofthe cell walls. This
is also supported by the lack of toxicity of supernatants of
mechanically disrupted or lysed pneumococci. Pneumococ-
cal cell walls showed some toxicity in vitro, but the cytotoxic
concentration of these fragments was at least 10 times higher
than that in CSF, and CSF obtained 6 h after intracisternal
injection of the pneumococcal cell wall but not the 2-h sam-
ple with the higher cell. wall concentration contained the
non-TNF-mediated cytotoxic component. While these re-
sults cannot conclusively rule out a role of a pneumococcal
factor in the non-TNF-mediated toxicity, they are compati-
ble with the hypothesis that pneumococci, but not gram-
negative bacterial stimuli, induce a host factor other than
TNF that is cytotoxic in the HN33.1 cells. The nature of this
factor is unclear, but several candidates seem unlikely on the
basis ofour results. IL-l is one of the cytokines found in the
CSF during meningitis [12, 29], and in human macrophages
pneumococcal cell walls are more potent stimuli ofIL-l than
is endotoxin [30]. However, IL-l failed to show any cytotox-
icity in HN33.1 cells. Excitatory amino acids such as gluta-
mate can cause neuronal injury via N-methyl-D-aspartate re-
ceptors [31] and are increased in the CSF during meningitis
(unpublished data), but HN33.1 cells are resistant to gluta-
mate. Finally, we examined arachidonic acid because of its
known cytotoxic effect on neurons [32, 33], but the concen-
trations that were cytotoxic to HN33.1 cells far exceeded
those that can be expected in infected CSF.
The identification of a cytotoxic factor associated with
pneumococcal meningitis poses several interesting questions
to be addressed in future studies. The chemical identity of
this factor and its specificity for cells of neuronal origin will
have to be worked out. Furthermore, it will be important to
examine this factor in primary neuronal cultures that may be
more indicative ofthe situation in vivo than the cell line used
here. Finally, once the neurotoxic factor is identified, we
hope to be able to determine its role in causing neuronal
injury in vivo.
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